Enter a Valid Email to Get Free Updates on New Research and News Updates:

Biotech And Biopharmaceutical Solutions Make Strong Gains In Late Morning

September 18th, 2009
Tags: , , , , , , ,

Calgary, Alberta - PicksThatMove.com opines promising trading opportunities with likely potential for gain. The companies we follow have favourable revenue models for business development at upward cycles.  To view more of our profiled stocks, please visit us at PicksThatMove.com

Biotech And Biopharmaceutical Solutions Make Strong Gains In Late Morning

The hot stock information of the day includes:  PDEX, RPRX

Pro-Dex, Inc. (NASDAQ:PDEX) jumped 27.66% up to $0.60 on news the company released Q10 fiscal results late yesterday.  Despite a decline in sales of 4% over the last three month period of operations, and 16% decline in sales since June 2008; the company boasted gross profits for the quarter ended June 30, 2009 increasing to $1.9 million, a 35% gross profit margin. The company also reported a gross profit of $6.7 million, an increase of 32% compared to gross profit of $8.2 million or 33% gross profit margin for the year-ago period.  Operating expenses for the fourth quarter decreased by 27% to $1.7 million, compared to $2.2 million in the fourth quarter 2008. The company disclosed it has a $9.6 million backlog of orders and revealed a new product launch is coming soon. Based in Irvine, California, Pro-Dex Inc is a motion control and power engineering company providing high-tech and refined drive systems for the medical, dental, semiconductor, scientific research and aerospace markets worldwide.

Repros Therapeutics Inc. (Public, NASDAQ:RPRX) advanced 45.45% up to $1.28 on no official news.  Based in The Woodlands, Texas, Repros Therapeutics is a development-stage biopharmaceutical company developing drug therapies for the treatment of serious female pelvic conditions, such as treatment of uterine fibroids, anemia associated with excessive menstrual bleeding relating to uterine fibroids, and anemia associated with uterine fibroids and endometriosis.  Repros Therapeutics has three late stage drug candidates in trials.

To be kept up to date on all of our hot stock information join us at Picks That Move.

About PicksThatMove.com:

PicksThatMove.com is an independent electronic publication that provides information on selected publicly traded companies.  PicksThatMove.com is not a registered investment advisor or broker-dealer.  PicksThatMove.com affiliates, officers, directors and employees may buy and sell shares in any company mentioned herein and may profit in the event those shares rise in value.  We recommend Due Diligence before investing in any stock.

Related posts:

  1. BSDM, RPRX Jump In Morning Trading BSDM up 45.51% on news the Journal of the National...
  2. RPRX Surges 57 Percent On FDA Guidance RPRX up 57.74% on guidance from the Division of Reproductive...
  3. QLTI Jumps On Settlement QLT will pay $20 million to the Massachusetts General Hospital...
  4. Repros Stock Surges On Positive Trial Results Repros Therapeutics Inc. skyrocketed 124.73% on news disclosed late yesterday,...
  5. Small Cap Biotech Making Strong Gains: SNSS, CYCC CYCC up 18.27% after hitting an intra-day high of $2.43....

Related posts brought to you by Yet Another Related Posts Plugin.

Sep
18
2009


Comments are closed.